Relationship between Preoperative Hemoglobin and Hospital Stays in Patients Receiving Prime Total Knee Arthroplasty

Cai, Xiao; Li, Peipei; Wang, Xue; Hu, Jing; Wen, Lian; Duan, Yajing; Mu, Zhenzhen; Zhi, Hong

doi:https://doi.org/10.1155/2022/3627688

Computational Intelligence and Neuroscience

On this page

Abstract Introduction Methods Results Discussion Conclusions Data Availability Conflicts of Interest Authors’ Contributions References Copyright Related Articles

Special Issue

Nature-inspired Computing for Web Intelligence

View this Special Issue

Research Article | Open Access

Volume 2022 | Article ID 3627688 | https://doi.org/10.1155/2022/3627688

Relationship between Preoperative Hemoglobin and Hospital Stays in Patients Receiving Prime Total Knee Arthroplasty

Xiao Cai,¹Peipei Li,²Xue Wang,¹Jing Hu,³Lian Wen,²Yajing Duan,²Zhenzhen Mu,²and Hong Zhi³

Academic Editor: Kapil Sharma

Received11 Apr 2022

Revised05 May 2022

Accepted30 Jun 2022

Published15 Jul 2022

Abstract

Previous evidence has shown that preoperative hemoglobin is related to poor prognosis after primary total knee arthroplasty. Reviewing cohort research was conducted at the third-level academic medical center in Singapore and involved 2,676 patients. Population statistics, complications, preoperative hemoglobin (Hb) levels, length of hospital stay (LOS), and readmission information of thirty days were obtained. Anemia was defined based on the World Health Organization (WHO). LOS extension was with the definition as no less than six days with >1/75 LOS corresponding to the data. According to the study requirements, we finally collected 2273 patients. We plotted the relationship between hemoglobin levels and length of stay. We analyzed 2273 patients, with 140 cases of Hb ≤ 11.0 g/dL, 831 cases of Hb 11.0–12.9 g/dL, and the other 1320 cases of Hb ≥ 13.0 g/dL. The mean age of patients with prolonged LOS (68.4 ± 8.2 years) was higher than that of patients with familiar LOS (65.9 ± 8.0 years). In addition, patients with extended LOS had higher ASA-PS values, a history of cerebrovascular accidents (CVA), diabetes mellitus (DM), and ischemic heart disease (IHD) (), repeated surgery within 30 days, HB, and operative time (min) (). Variables independently related to increased risk of extended LOS included general anesthesia (GA) (adjusted OR (aOR) 1.4, , ), CVA (aOR 3.0, ), DM (aOR 1.4, ), and HB < 11 g/dL. Variables increased LOS included HB ≥ 13 g/dL (aOR 0.4, ) and Hb 11.0–12.9 g/dL (aOR 0.5, ). Hb was 14 g/dL, and LOS decreased by at least 0.24 days for each 1 g increase in preoperative Hb before the inflection point (95%CI 0.12 to 0.36, ). Anemia is familiar in patients receiving elective total knee arthroplasty (TKA) in Singapore. Thus, this study describes that the preoperative hemoglobin was associated with length of stay. We found that on the left where HB was 14, length of stay decreased with increased hemoglobin values. We recommend preoperative correction of anemia to determine the diagnosis.

1. Introduction

The TKA is a normal surgical therapy for knee degeneration, which is a common disease in the elderly [1]. Meanwhile, TKA is now the most familiar surgical process in the world [2]. Preoperative anemia impacts one-third to two-thirds of sick persons receiving main elected surgery and is related to the increased risk of blood transfusion, hospitalization complications, delayed discharge, and poor recoveries [3, 4]. Recently, Baron et al. [5] studied nearly 40,000 surgical patients in twenty-eight countries in Europe. By surprise, nearly 30% of patients indicated anemia related to the extended hospital stay and increasing death risk in the hospital before operation. In a previous study, led by Lasocki et al. [6], 1534 patients underwent elective internal knee and hip arthroplasty and spinal surgery at 17 European centers. The preoperative prevalence of anemia was 14.1% and over 85.0% at discharge. Meanwhile, lots of research studies have verified the validity of anemia management before surgery [7–13]. Similarly, many research studies on the relationship between the length of hospital stay after joint replacement and preoperative anemia [14–20] have been performed in Western healthcare settings with diverse demographic statistics and possibly different discharge and rehabilitation policies in other parts of the world.

Thus, this study analyzed the effects of preoperative anemia on the length of hospitalization in patients without blood transfusion during the initial total knee arthroplasty.

2. Methods

2.1. Participants and Data Source

The information for this study uses data from a single-center reviewing study article published by Hairil Rizal Abdullah et al. [21]. The data can be reached via the full dataset used in the analysis that can be downloaded from Dryad public repository at doi:10.5061/dryad.73250. We analyzed electronic medical records of 2,676 patients treated with TKA at Singapore General Hospital between January 2013 and June 2014. The records were obtained from the Singapore General Hospital clinic data system and kept in the Singapore General Hospital company database and analytical system. It combines information from executive management clinic and assistant healthcare institutions. Data from SCM include patient demographic statistics, preoperative complications like smoking, the level of hemoglobin (Hb), personal components of the revised risk cardiac index (RCRI) [22, 23], past records of former CVAs, DM on insulin, and increased preoperative creatinine level >2 mg/dL; ASA-PS value [24]; particulars of surgery like location, time, form of anesthesia, and what day of the week the operation took place [25]; and perioperative blood transfusion and repetitive operations during hospitalization. LOS was counted from the day of permission to the day of discharge to home circumstances. Data on 30-day postdischarge readmission were collected from the clinical information system database, SCM. We diagnostic screened for related readmissions through the internet-classified diseases (10th edition) and further identified the reason for admission by reviewing the electronic medical records of patients. We determined a time window for preoperative hemoglobin levels, at most fourteen days and at least one day before operation. In Singapore General Hospital, many patients are permitted on the day of operation for medical and/or social reasons, and rarely, 1 day earlier.

In general, all antiplatelet drugs except aspirin are discontinued before the recommended time of operation. Intraoperative infiltration of the knee with tranexamic acid, intravenous infusion of tranexamic acid, and postoperative drainage into the joint are not standardized. Cell rescue is scarce. After surgery, all patients accepted normal hospital TKA protocol of postoperative care and discharge. Patients received regular physical therapy from the day after surgery, even on the weekends. It contains several procedures to climb, a walking framework to transfer with assistance, and bend the surgically operated knee nearly 90 degrees. After eliminating fifty-one patients with more than 3 variable deletions, 3 patients without preoperative Hb levels, twenty-two patients undergoing revision operation, one hundred and twenty-one patients undergoing preoperative transfusion, and two hundred and six patients undergoing a bilateral operation, we gathered a final analysis of 2273 patients (Figure 1). Due to the small number of data (2.0%), no sensitivity analysis was performed on the missing data.

The primary endpoint was LOS prolongation, with a definition of no less than six days. The cutoff was chosen because it represents >75 centiles for the entire sample. The usage of 75 centimeters to define LOS extension is in accordance with other research studies [26].

2.2. Statistical Analysis¶

Demographic statistics and clinic features of patients were compared (Table 1). We classified age, body mass index (BMI), and duration of surgery by ≤100 min or >100 min (1/75 of > data). A gain in LOS was also determined by using a multivariate logistic regression (Table 2). We applied WHO gender-based definition of anemia seriousness [22]. In the end, we used the data to determine independent predictors of LOS using curve models (Figure 1), while adjusting for demographic factors (Figure 2). Moreover, according to the curve model, we found that the length of hospitalization decreased with increasing Hb levels, but the Hb reached a certain level changed not significantly with increasing hemoglobin levels. Therefore, we propose a threshold effect analysis method based on the curve model to find the inflection point of the curve (Table 2). We apply smooth curve fitting to test whether the independent variables are divided into intervals for the first time. We use piecewise regression (also called piecewise regression), which applies respective line segments to suit every interval. A logarithmic likelihood ratio test was used to compare the single-line (nonpiecewise) model with the piecewise regression model to decide whether the threshold existed. On this basis, the maximum likelihood of the binding point is determined by a two-step recursive approach. Step 1 is to narrow down the inflection point to a 10 percentile range of the independent variable. From 5% to 95% increment by 5%, we test 19 segmented regression models using these 19 percentile points of the independent variable as the inflection point, respectively, to find out which percentile points give the model with the highest likelihood. The precise inflection point was narrowed down to ± 4% percentile of the percentile points, which gives the highest likelihood among the 19 models, called Kmin and Kmax, respectively. Step 2 is to determine the precise inflection point between Kmin and Kmax using the recursive method. The specific method is to first run 3 models with inflection points that equal Q1 (one fourth), Q2 (one half), and Q3 (three fourths) within the range in Kmin and Kmax, respectively, to find out which quartile point gives the model with the highest likelihood among the three models. Then, we narrow down the Kmin and Kmax to the range of ± 25% of the corresponding quartile point. By doing so, we narrow down the range of Kmin and Kmax 50% recursively each time until the specific value of the independent variable was identified, which if used as inflection point will give the segmented regression model the highest likelihood.

3. Results

3.1. Demographics

There were totally 2273 patients undergoing prime TKA met inclusion. A total of 140 patients were with Hb ≤ 11.0 g/dL, 831 with Hb 11.0–12.9 g/dL, and 1320 with Hb ≥ 13.0 g/dL. In Table 1, the mean age of patients with prolonged LOS (68.4 ± 8.2 years) was higher. There were no evident distinctions in BMI, sex, and anesthesia type in two parts. However, patients with extended LOS wanted to have higher ASA-PS values.

3.2. Effects of Hb on LOS¶

The mean LOS in TKA patients was 5.4 days (±4.8 days). The consequences are resembled to former issued LOS ratios [27]. Three hundred and ninety-four patients (17.3%) had LOS over six days (i.e., prolonged LOS). According to a multicomponent study, the variables related to independent increasing risk of extended LOS contain having GA (aOR 1.4, ), previous CVA (aOR 3.0, ), previous DM (aOR 1.4, ), and HB < 11 g/dL. Variables with decreased LOS contain HB ≥ 13 g/dL (aOR 0.4, ) and Hb 11.0–12.9 g/dL (aOR 0.5, ). BMI, sex, existence of DM on insulin, former diagnosis of IHD, and creatinine >2 mg/dL were not related to a higher occurrence rate of extended LOS (Table 2).

As mentioned earlier, we performed a multivariate logistic regression analysis of LOS and used gender-based Hb cutoff values. The aOR of HB 11.0–12.9 g/dL was 0.5, and hospital stay was 50% shorter. HB ≥ 13 g/dL extended hospital stay, aOR was 0.4 (0.2, 0.6, ), and hospital stay was 60% shorter (>6 days).

As shown in Figures 2 and 3, as the Hb protein value changed, it was observed that when Hb is around 14 g/dL, to the left of its value, hospital stay decreases with an increasing hemoglobin value; after adjusting for demographic characteristics such as sex, age, and BMI, the inflection point of the curve changed little. To obtain the accurate inflection point value, we applied the threshold effect analysis based on the curve model to find the inflection point of the curve (Table 3), Hb was 14 g/dL, and for every 1 g of preoperative Hb increase before the inflection point, the LOS decreased by at least 0.24 days.

4. Discussion

About one-third of the patients undergoing elective total joint arthroplasty developed anemia without preoperative treatment [4, 5].

Many observed research studies have summarized that preoperative anemia must be thought of as an independent risk element for red blood cell transfusion, latent complications, and postoperative death rate [5, 28, 29]. In this study, with LOS ≤ 6 and HB < 11 g/dL, the prevalence of preoperative moderately severe anemia was 4.6%, LOS > 6, and HB < 11 g/dL was 10.2%. For LOS ≤ 6 and Hb11.0–12.9 g/dL, the prevalence of preoperative mild anemia was 36.2%; for LOS > 6 and Hb11.0–12.9 g/dL, the preoperative prevalence of mild anemia was 41.4%. In our analysis, hemoglobin values were associated with length of stay.

Our results are consistent with former research studies that preoperative anemia independently adds LOS in “fast-track” knee replacement [15] and “conventional” elective prime knee replacement [30]. Therefore, according to current S3 guidelines [31], preoperative diagnosis of anemia should be timely. In this regard, early confirmation of patients with anemia (at least two-four weeks before surgery) is key to surgical preparation. This study now focuses on changes in hemoglobin and length of stay of the TKA patient. Our study indicates in the area of selective orthopedic TKA patient care; on the left where HB was 14 g/dL, length of stay decreased with increased hemoglobin values. Compared with HB < 11 g/dL, aOR 0.5 (0.3, 0.3, ) and days in hospital were 50% less while Hb ≥ 13 g/dL with aOR of 0.4 (0.2, 0.6, ) of extended LOS and days in hospital were 60% less (>6 days).

The information supports the requirement to cure preoperative anemia as a section of TKA processes in future. Kotze et al. [32] declared resembled success in preoperative anemia management in orthopedic patients. Our research increases to the number of publications from Asia on the negative effect of preoperative anemia on postoperative results of orthopedic and nonorthopedic processes. [33, 34]. The reasons for anemia in orthopedic/trauma patients are various [15, 35–37]. Anemia, at least in these patients, resulted in lack of iron, in a recent study of orthopedic knee patients in Denmark.

Jans et al. [38] indicated over forty percent of patients with anemia showed iron lack. For example, Theusinger et al. [39] have demonstrated the advantages of preoperative anemia management, especially in patients undergoing elective orthopedic surgery. We found that chronic anemia similar to aOR uses the gender definition of anemia, with the definition of mild anemia as 11.0 and 12.9 g/dL in men and 11.0 and 11.9 g/dL in women. Thus, this supports the present proposal that preoperative anemia should be defined at the gender-neutral threshold of <13.0 g/dL for patient blood management purposes [40, 41]. It showed that the curvilinear relationship between hemoglobin value and length of stay, on the left where the hemoglobin value was 14 g/dL and decreased with increasing hemoglobin value, was in line with clinical facts.

Another advantage of our research is that we concluded both subjective tests of clinic risk evaluation: ASA-PS score and RCRI. This study indicated that among the five clinic conditions in the RCRI value range, GA (aOR 1.4, P=0.005), previous CVA (aOR 3.0, P<0.001), and previous DM (aOR 1.4, P=0.032) were associated with increased LOS.

In the end, this study focused on patients who underwent prime TKA, rather than patients who had both hip and knee arthroplasty, which is more common in the literature because we needed a more similar study population. We eliminated revision, perioperative transfusion, and bilateral TKA because these were associated in the literature with an increased need for transfusion and LOS [42, 43]. Our study recruited over a year and a half year. Our recruitment period was resembled to that of another research issued on the theme, which recruited over two years [15].

Because of the observed property of the research, it is difficult to establish a causal relationship between preoperative anemia and negative effects. Furthermore, although our choice of the 75th percentile to define prolonged LOS can be seen as arbitrary truncation in the absence of a widespread definition of extended LOS, similar studies [26] have used the 75th percentile in previous literature. We also do not have data on prevalent intraoperative usage of tranexamic acid that penetrates into the joint, intravenous use of tranexamic acid by anesthesiologists [44–46].

5. Conclusions

In conclusion, preoperative hemoglobin was associated with length of stay. We found that on the left where HB was 14, length of stay decreased with increased hemoglobin values. We recommend corrective anemia before operation, containing the usage of a non-sex-based Hb cutoff to determine the diagnosis.

Data Availability

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors’ Contributions

Xiao Cai and Peipei Li contributed equally to this work.

References

C. W. Decker and R. C. Decker, “Total joint arthroplasty for persons with osteoarthritis,” PM&R, vol. 4, no. 5 Suppl, pp. S97–S103, 2012.
View at: Publisher Site | Google Scholar
A. J. Carr, O. Graves, N. K. Arden, A. Judge, and D. J. Beard, “Knee replacement,” The Lancet, vol. 379, no. 9823, pp. 1331–1340, 2012.
View at: Publisher Site | Google Scholar
A. J. Fowler, T. Ahmad, M. K. Phull, S. Allard, M. A. Pearse, and R. M. Pearse, “Meta-analysis of the association between preoperative anaemia and mortality after surgery,” British Journal of Surgery, vol. 102, no. 11, pp. 1314–1324, 2015.
View at: Publisher Site | Google Scholar
K. M. Musallam, H. M. Richards, T. Rosendaal, J. J. HabbalKhreissDahdalehKhavandiSfeirSoweidHoballahTaherJamali, A. T. Taher, and F. R. Jamali, “Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study,” The Lancet, vol. 378, no. 9800, pp. 1396–1407, 2011.
View at: Publisher Site | Google Scholar
D. M. Baron, H. Posch, M. Rhodes, R. MorenoPearseMetnitz, R. Pearse, and P. Metnitz, “Preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery patients,” British Journal of Anaesthesia, vol. 113, no. 3, pp. 416–423, 2014.
View at: Publisher Site | Google Scholar
S. Lasocki, R. Krauspe, C. von Heymann, A. Mezzacasa, S. Spahn, and D. R. Spahn, “Prepare,” European Journal of Anaesthesiology, vol. 32, no. 3, pp. 160–167, 2015.
View at: Publisher Site | Google Scholar
O. M. Theusinger, P. F. Leyvraz, U. Schanz, B. Spahn, and D. R. Spahn, “Treatment of iron deficiency anemia in orthopedic surgery with intravenous iron: efficacy and limits,” Anesthesiology, vol. 107, no. 6, pp. 923–927, 2007.
View at: Publisher Site | Google Scholar
E. Bisbe, J. A. García-Erce, A. I. Díez-Lobo, and M. Muñoz, “A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery,” British Journal of Anaesthesia, vol. 107, no. 3, pp. 477-478, 2011.
View at: Publisher Site | Google Scholar
M. Muñoz, S. Gómez-Ramírez, J. García-Erce, D. Iglesias-AparicioHaman-AlcoberArizaNaveira, and E. Naveira, “Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients,” Transfusion, vol. 54, no. 2, pp. a–n, 2013.
View at: Publisher Site | Google Scholar
C. Camaschella, “Iron-deficiency anemia,” New England Journal of Medicine, vol. 372, no. 19, pp. 1832–1843, 2015.
View at: Publisher Site | Google Scholar
P. I. Johansson, A. S. Thomsen, and L. L. Thomsen, “Intravenous iron isomaltoside 1000 (Monofer ) reduces postoperative anaemia in preoperatively non‐anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double‐blind placebo‐controlled clinical trial (the PROTECT trial),” Vox Sanguinis, vol. 109, no. 3, pp. 257–266, 2015.
View at: Publisher Site | Google Scholar
T. A. Koch, J. Goodnough, and L. T. Goodnough, “Intravenous iron therapy in patients with iron deficiency anemia: dosing considerations,” Anemia, vol. 2015, pp. 1–10, 2015.
View at: Publisher Site | Google Scholar
B. Froessler, P. Palm, I. Weber, N. A. Hodyl, R. Murphy, and E. M. Murphy, “The important role for intravenous iron in perioperative patient blood management in major abdominal surgery,” Annals of Surgery, vol. 264, no. 1, pp. 41–46, 2016.
View at: Publisher Site | Google Scholar
E. Liodakis, S. G. Bergeron, D. J. Zukor, O. L. Huk, L. M. Antoniou, and J. Antoniou, “Perioperative complications and length of stay after revision total hip and knee arthroplasties: an analysis of the NSQIP database,” The Journal of Arthroplasty, vol. 30, no. 11, pp. 1868–1871, 2015.
View at: Publisher Site | Google Scholar
O. Jans, C. Jørgensen, H. Johansson, and P. I. Johansson, “Role of preoperative anemia for risk of transfusion and postoperative morbidity in fast-track hip and knee arthroplasty,” Transfusion, vol. 54, no. 3, pp. 717–726, 2014.
View at: Publisher Site | Google Scholar
J. Viola, M. M. Gomez, C. Restrepo, M. G. Parvizi, and J. Parvizi, “Preoperative anemia increases postoperative complications and mortality following total joint arthroplasty,” The Journal of Arthroplasty, vol. 30, no. 5, pp. 846–848, 2015.
View at: Publisher Site | Google Scholar
J. S. Chamieh, H. M. Tamim, K. Z. Masrouha, S. S. Al-Taki, and M. M. Al-Taki, “The association of anemia and its severity with cardiac outcomes and mortality after total knee arthroplasty in noncardiac patients,” The Journal of Arthroplasty, vol. 31, no. 4, pp. 766–770, 2016.
View at: Publisher Site | Google Scholar
F. T. Pitter, C. C. Jørgensen, M. Lindberg-Larsen, and H. Kehlet, “Postoperative morbidity and discharge destinations after fast-track hip and knee arthroplasty in patients older than 85 years,” Anesthesia & Analgesia, vol. 122, no. 6, pp. 1807–1815, 2016.
View at: Publisher Site | Google Scholar
M. Greenky, K. Gandhi, L. Pulido, C. Parvizi, and J. Parvizi, “Preoperative anemia in total joint arthroplasty: is it associated with periprosthetic joint infection?” Clinical Orthopaedics and Related Research, vol. 470, no. 10, pp. 2695–2701, 2012.
View at: Publisher Site | Google Scholar
H. Husted, G. Jacobsen, and S. Jacobsen, “Predictors of length of stay and patient satisfaction after hip and knee replacement surgery: fast-track experience in 712 patients,” Acta Orthopaedica, vol. 79, no. 2, pp. 168–173, 2008.
View at: Publisher Site | Google Scholar
H. R. Abdullah, Y. Hao, Y. Liew, G. H. C. LamoureuxTan, E. L. Lamoureux, and M. H. Tan, “Association between preoperative anaemia with length of hospital stay among patients undergoing primary total knee arthroplasty in Singapore: a single-centre retrospective study,” BMJ Open, vol. 7, no. 6, p. e016403, 2017.
View at: Publisher Site | Google Scholar
L. A. Fleisher, K. E. Auerbach, J. A. Beckman, H. H. BozkurtDavila-RomanGerhard-HermanHollyKaneMarineNelsonSpencerThompsonTingUretskyWijeysundera, B. F. Uretsky, and D. N. Wijeysundera, “2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary,” Circulation, vol. 130, no. 24, pp. 2215–2245, 2014.
View at: Publisher Site | Google Scholar
T. H. Lee, E. R. Mangione, C. M. Polanczyk, L. E. CookSugarbakerDonaldsonPossHoLudwigPedanGoldman, A. Pedan, and L. Goldman, “Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery,” Circulation, vol. 100, no. 10, pp. 1043–1049, 1999.
View at: Publisher Site | Google Scholar
E. O. Bryson and C. H. Kellner, “Psychiatric diagnosis counts as severe systemic illness in the American Society of Anesthesiologists (ASA) physical status classification system,” Medical Hypotheses, vol. 83, no. 4, pp. 423-424, 2014 Oct.
View at: Publisher Site | Google Scholar
J. M. Newman, C. R. Szubski, W. K. Barsoum, C. A. Higuera, R. M. Murray, and T. G. Murray, “Day of surgery affects length of stay and charges in primary total hip and knee arthroplasty,” The Journal of Arthroplasty, vol. 32, no. 1, pp. 11–15, 2017.
View at: Publisher Site | Google Scholar
A. Almashrafi, H. Alsabti, M. Mukaddirov, B. Aylin, and P. Aylin, “Factors associated with prolonged length of stay following cardiac surgery in a major referral hospital in Oman: a retrospective observational study,” BMJ Open, vol. 6, no. 6, p. e010764, 2016.
View at: Publisher Site | Google Scholar
J. Y. Chen, W. C. Lee, H. Y. Chan, P. C. C. Chang, N. N. Lo, and S. J. Yeo, “Drain use in total knee arthroplasty is neither associated with a greater transfusion rate nor a longer hospital stay,” International Orthopaedics, vol. 40, no. 12, pp. 2505–2509, 2016.
View at: Publisher Site | Google Scholar
C. Con Heymann, L. Sander, M. Schmidt, H. GombotzWerneckeBalzer, K. D. Wernecke, and F. Balzer, “Does the severity of preoperative anemia or blood transfusion have a stronger impact on long-term survival after cardiac surgery?” The Journal of Thoracic and Cardiovascular Surgery, vol. 152, no. 5, pp. 1412–1420, 2016.
View at: Publisher Site | Google Scholar
D. R. Spahn, “Anemia and patient blood management in hip and knee surgery,” Anesthesiology, vol. 113, no. 2, pp. 482–495, 2010.
View at: Publisher Site | Google Scholar
I. D. M. Smith, R. Elton, J. A. Brenkel, and I. J. Brenkel, “Pre-operative predictors of the length of hospital stay in total knee replacement,” Journal of Bone and Joint Surgery British Volume, vol. 90-B, no. 11, pp. 1435–1440, 2008.
View at: Publisher Site | Google Scholar
C. Rosenthal, C. von Heymann, and L. Kaufner, “Diagnostik und Behandlung der präoperativen Anämie,” Anaesthesist, Der, vol. 68, no. 8, pp. 555–567, 2019.
View at: Publisher Site | Google Scholar
A. Kotzé, L. A. Scally, and A. J. Scally, “Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle,” British Journal of Anaesthesia, vol. 108, no. 6, pp. 943–952, 2012.
View at: Publisher Site | Google Scholar
D. H. Jung, H. J. Han, D. S. Kong, S. H. LeeYang, K. U. Lee, and H. K. Yang, “Impact of perioperative hemoglobin levels on postoperative outcomes in gastric cancer surgery,” Gastric Cancer, vol. 16, no. 3, pp. 377–382, 2013.
View at: Publisher Site | Google Scholar
L. Zhang, P. Lv, H. Gao, Y. ZhangTang, L. Zhang, and P. Tang, “Anemia on admission is an independent predictor of long-term mortality in hip fracture population,” Medicine, vol. 95, no. 5, p. e2469, 2016.
View at: Publisher Site | Google Scholar
L. T. Schrier and S. L. Schrier, “Evaluation and management of anemia in the elderly,” American Journal of Hematology, vol. 89, no. 1, pp. 88–96, 2014.
View at: Publisher Site | Google Scholar
N. J. Kassebaum, R. Naghavi, M. Johns, R. L. LozanoReganWeatherallChouEiseleFlaxmanPullan BrookerMurray, S. J. Brooker, and C. J. L. Murray, “A systematic analysis of global anemia burden from 1990 to 2010,” Blood, vol. 123, no. 5, pp. 615–624, 2014.
View at: Publisher Site | Google Scholar
G. Goodnough and L. T. Goodnough, “Anemia of chronic disease,” New England Journal of Medicine, vol. 352, no. 10, pp. 1011–1023, 2005.
View at: Publisher Site | Google Scholar
O. Jans, C. S. Nielsen, N. Khan, K. Gromov, A. Husted, and H. Husted, “Iron deficiency and preoperative anaemia in patients scheduled for elective hip- and knee arthroplasty - an observational study,” Vox Sanguinis, vol. 113, no. 3, pp. 260–267, 2018.
View at: Publisher Site | Google Scholar
O. M. Theusinger, S. L. Kind, B. Seifert, L. Borgeat, C. Spahn, and D. R. Spahn, “Patient blood management in orthopaedic surgery: a four-year follow-up of transfusion requirements and blood loss from 2008 to 2011 at the Balgrist University Hospital in Zurich, Switzerland,” Blood transfusion = Trasfusione del sangue, vol. 12, no. 2, pp. 195–203, 2014.
View at: Publisher Site | Google Scholar
M. Muñoz, S. Gómez-Ramírez, S. Kozek-Langeneker, and M. ShanderRichardsPavíaKehletAchesonEvansRaobaikady JavidrooziAuerbach, “‘Fit to fly’: overcoming barriers to preoperative haemoglobin optimization in surgical patients †,” British Journal of Anaesthesia, vol. 115, no. 1, pp. 15–24, 2015.
View at: Publisher Site | Google Scholar
M. Muñoz, A. G. Auerbach, M. Hable, C. KehletLiumbrunoLasockiMeybohmRao BaikadyRichardsShanderSo-OsmanSpahnKlein, D. R. Spahn, and A. A. Klein, “International consensus statement on the peri-operative management of anaemia and iron deficiency,” Anaesthesia, vol. 72, no. 2, pp. 233–247, 2017.
View at: Publisher Site | Google Scholar
J. J. Spitzer and A. I. Spitzer, “Blood management and patient specific transfusion options in total joint replacement surgery,” The Iowa Orthopaedic Journal, vol. 20, pp. 36–45, 2000.
View at: Google Scholar
J. J. Callaghan and A. I. Spitzer, “Blood management and patient specific transfusion options in total joint replacement surgery,” The Iowa Orthopaedic Journal, vol. 20, pp. 36–45, 2000.
View at: Google Scholar
G. J. Murphy, B. C. Reeves, C. A. Rogers, S. I. Rizvi, L. Angelini, and G. D. Angelini, “Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery,” Circulation, vol. 116, no. 22, pp. 2544–2552, 2007.
View at: Publisher Site | Google Scholar
Z. K. McQuilten, N. van de Watering, L. Aubron, J. J. PhillipsBellomoPilcherCameronReidCole-SinclairNewcombSmithMcNeilWood, and E. M. Wood, “Introduction of universal prestorage leukodepletion of blood components, and outcomes in transfused cardiac surgery patients,” The Journal of Thoracic and Cardiovascular Surgery, vol. 150, no. 1, pp. 216–222, 2015.
View at: Publisher Site | Google Scholar
F. C. Althoff, H. Herrmann, E. Vernich, K. FüllenbachFreedmanWatersFarmerLeahyZacharowski MeybohmChoorapoikayil, P. Meybohm, and S. Choorapoikayil, “Multimodal patient blood management program based on a three-pillar strategy,” Annals of Surgery, vol. 269, no. 5, pp. 794–804, 2019.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2022 Xiao Cai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies